Evidence map›Paper›PMID 39607608›Full record

ArticleEuropean journal of nutrition2024

Association between serum carotenoids and migraine in adults: a cross-sectional study from NHANES data.

Wenyuan Zhang, Zicheng Cheng, Fangwang Fu, Zhenxiang Zhan, Shuyue Lou, Saizhen Wu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenyuan Zhang *Department of Neurology, Affiliated Yueqing Hospital of Wenzhou Medical University, No.338 Qingyuan Road, Yueqing, Zhejiang Province, 325600, China.ORCID http://orcid.org/0000-0002-4831-6413
Zicheng Cheng *Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.ORCID http://orcid.org/0000-0002-9171-6084
Fangwang FuDepartment of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Zhenxiang ZhanDepartment of Neurology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Shuyue LouDepartment of Neurology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Saizhen WuDepartment of Neurology, Affiliated Yueqing Hospital of Wenzhou Medical University, No.338 Qingyuan Road, Yueqing, Zhejiang Province, 325600, China. 15988576707@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known regarding the impact of serum carotenoids, a class of compounds having anti-inflammatory and antioxidant properties, on migraine. This study aimed to examine the association between serum carotenoid levels and migraine risk among United States adults.

methodsThis cross-sectional study recruited 7744 individuals aged 20 years or older from the National Health and Nutrition Examination Survey conducted between 2001 and 2004. The concentrations of five serum carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lycopene, and lutein + zeaxanthin) and retinol were measured using high-performance liquid chromatography. Migraine was diagnosed when participants reported that they had severe headaches or migraines during the past three months. Weighted multivariable logistic regression and restricted cubic spline models were used to determine the association between serum carotenoid levels and migraine risk.

resultsAmong the 7744 participants enrolled in the study, 1595 (20.6%) had migraine. Compared with the lowest quartiles, the highest quartiles of the three serum carotenoids were associated with a lower risk of migraine, with a multivariable-adjusted odds ratio (OR) of 0.74 (95% confidence interval [CI], 0.57-0.97) for α-carotene, 0.64 (95% CI, 0.49-0.83) for β-carotene, and 0.64 (95% CI, 0.53-0.78) for lutein + zeaxanthin, while the third quartile of serum β-cryptoxanthin had lower odds of migraine (OR, 0.70; 95% CI, 0.54-0.90). The U-shaped patterns of nonlinear relationships between serum β-cryptoxanthin and lutein + zeaxanthin levels and migraine risk were represented by restricted cubic splines. No association was observed between serum lycopene and retinol levels and migraine.

conclusionsLow serum carotenoid levels were associated with an increased risk of migraine. Further prospective investigations are warranted to clarify the causative relationship and explore the possible prevention and treatment of migraine using carotenoid supplementation.

Indexed as

CarotenoidsMigraine DisordersNutrition SurveysAdultAgedbeta CaroteneCross-Sectional StudiesFemaleHumansLuteinMaleMiddle AgedRisk FactorsUnited StatesYoung AdultZeaxanthinsalpha-carotenebeta CaroteneCarotenoidsLuteinZeaxanthinsAnti-inflammationAntioxidantCarotenoidMigraineNational health and nutrition examination survey

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.